Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Raquel Sánchez Valle, coordinator of the Behavior and Dementia Group of the Spanish Society ... Given the complexity of ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

Because of this, medications that reduce iron overload by binding to iron, a process that’s called chelation, have received a good deal of attention as potential treatments for Alzheimer’s ...

Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

As people age, the body changes as part of the normal ageing process, such as greying hair and loss of elasticity in the skin ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

A compassionate, multidisciplinary approach can help manage one of the most complex challenges nursing homes and other long-term care providers face.